Creo Medical (1RC) Financial Statements
Creo Medical Financial Overview
Creo Medical's market cap is currently $61.08M. The company's EPS TTM is $0.01; its P/E ratio is -2.51; Creo Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.00M | $ 4.00M | $ 4.00M | $ 27.17M | $ 25.16M |
| Gross Profit | $ 1.40M | $ 1.90M | $ 15.30M | $ 10.01M | $ 9.02M |
| Operating Income | $ -20.70M | $ -28.80M | $ -24.80M | $ -30.81M | $ -29.96M |
| EBITDA | $ -19.70M | $ -26.10M | $ -20.70M | $ -27.62M | $ -27.54M |
| Net Income | $ 5.30M | $ -28.70M | $ -21.70M | $ -26.94M | $ -24.59M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.40M | $ 8.70M | $ 18.50M | $ 13.10M | $ 43.53M |
| Total Assets | $ 59.10M | $ 65.00M | $ 76.60M | $ 75.34M | $ 100.61M |
| Total Debt | $ 4.10M | $ 4.40M | $ 8.30M | $ 11.70M | $ 10.56M |
| Net Debt | $ -8.30M | $ -4.30M | $ 5.30M | $ -1.40M | $ -32.98M |
| Total Liabilities | $ 9.10M | $ 22.60M | $ 16.80M | $ 25.93M | $ 27.29M |
| Stockholders' Equity | $ 50.00M | $ 42.40M | $ 59.80M | $ 49.40M | $ 73.32M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.00M | $ -22.60M | $ -22.80M | $ -28.26M | $ -32.10M |
| Operating Cash Flow | $ -18.60M | $ -22.20M | $ -21.60M | $ -24.99M | $ -25.98M |
| Investing Cash Flow | $ 19.40M | $ 15.30M | $ -18.30M | $ -6.03M | $ -7.87M |
| Financing Cash Flow | $ -700.00K | $ 16.20M | $ 29.80M | $ 400.00K | $ 31.99M |
Currency in GBP